Dare Bioscience
DARE
37 hedge funds and large institutions have $8.07M invested in Dare Bioscience in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 7 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 4
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
26% more capital invested
Capital invested by funds: $6.4M → $8.07M (+$1.67M)
9% more funds holding
Funds holding: 34 → 37 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less ownership
Funds ownership: 0.57% → 0.57% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$421K |
| 2 |
Renaissance Technologies
New York
|
+$413K |
| 3 |
Goldman Sachs
New York
|
+$390K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$370K |
| 5 |
Jane Street
New York
|
+$298K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$104K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$84K |
| 3 |
Two Sigma Advisers
New York
|
-$62K |
| 4 |
BlackRock
New York
|
-$20K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$17.2K |
DARE Hedge Fund Activity: Q3 2021 in Review
37 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2021, worth a combined $8.07M — up 26% from $6.4M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new DARE positions and 7 closed out — a net gain of 3 holders — while 12 added to existing stakes and 4 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $421K. The largest seller was Morgan Stanley, cutting an estimated $104K.
- 37 institutional investors held Dare Bioscience (DARE) as of Q3 2021, up from 34 in Q2 2021.
- Funds reported $8.07M of Dare Bioscience stock for Q3 2021, up 26% quarter-over-quarter.
- 10 funds opened new Dare Bioscience positions in Q3 2021 and 7 closed out, a net change of +3 holders.
- The largest Dare Bioscience buyer in Q3 2021 was Geode Capital Management, an estimated $421K added.
- The largest Dare Bioscience seller in Q3 2021 was Morgan Stanley, an estimated $104K sold.
Based on aggregated 13F filings for Q3 2021.